Wikidata entity: Q412197
C₃₃H₃₈N₄O₆ (P274)
Quantities
| P2067 | mass | 586.279 |
| P3780 | active ingredient in | ... | Q47521310 (Camptosar) | Camptosar |
| P233 | canonical SMILES | String | CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 | ??? |
| P373 | Commons category | String | Irinotecan | ??? |
| P703 | found in taxon | ... | Q257106 (liquorice) | liquorice |
| P703 | found in taxon | ... | Q15636116 (Taiwanofungus camphoratus) | Taiwanofungus camphoratus |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 | ??? |
| P2175 | medical condition treated | ... | Q29496 (leukemia) | leukemia |
| P2175 | medical condition treated | ... | Q128581 (breast cancer) | breast cancer |
| P2175 | medical condition treated | ... | Q188874 (colorectal cancer) | colorectal cancer |
| P2175 | medical condition treated | ... | Q189588 (stomach cancer) | stomach cancer |
| P2175 | medical condition treated | ... | Q212961 (pancreatic cancer) | pancreatic cancer |
| P2175 | medical condition treated | ... | Q208414 (lymphoma) | lymphoma |
| P2175 | medical condition treated | ... | Q55998694 (neuroblastoma, susceptibility to) | neuroblastoma, susceptibility to |
| P2175 | medical condition treated | ... | Q4737958 (alveolar rhabdomyosarcoma) | alveolar rhabdomyosarcoma |
| P2175 | medical condition treated | ... | Q9303627 (brain cancer) | brain cancer |
| P2175 | medical condition treated | ... | Q18554959 (rectum adenocarcinoma) | rectum adenocarcinoma |
| P2175 | medical condition treated | ... | Q18555025 (colon cancer) | colon cancer |
| P2175 | medical condition treated | ... | Q18555055 (colon adenocarcinoma) | colon adenocarcinoma |
| P2175 | medical condition treated | ... | Q18555061 (colonic benign neoplasm) | colonic benign neoplasm |
| P2175 | medical condition treated | ... | Q18555254 (germ cell cancer) | germ cell cancer |
| P2175 | medical condition treated | ... | Q18556189 (pancreatic adenocarcinoma) | pancreatic adenocarcinoma |
| P2175 | medical condition treated | ... | Q2739660 (rectum cancer) | rectum cancer |
| P2175 | medical condition treated | ... | Q3658562 (non-small-cell lung carcinoma) | non-small-cell lung carcinoma |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q411478 (fluconazole) | fluconazole |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q416632 (nefazodone) | nefazodone |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q422198 (amprenavir) | amprenavir |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q422585 (lopinavir) | lopinavir |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q422654 (saquinavir) | saquinavir |
| P769 | significant drug interaction | ... | Q423366 (nelfinavir) | nelfinavir |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q409492 (cimetidine) | cimetidine |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q423404 (tipranavir) | tipranavir |
| P769 | significant drug interaction | ... | Q423467 (atazanavir) | atazanavir |
| P769 | significant drug interaction | ... | Q425490 (indinavir) | indinavir |
| P769 | significant drug interaction | ... | Q621834 (aprepitant) | aprepitant |
| P769 | significant drug interaction | ... | Q1385311 (fosamprenavir) | fosamprenavir |
| P769 | significant drug interaction | ... | Q2736135 (telithromycin) | telithromycin |
| P769 | significant drug interaction | ... | Q5908266 (idelalisib) | idelalisib |
| P769 | significant drug interaction | ... | Q3765251 (darunavir) | darunavir |
| P279 | subclass of | ... | Q26989371 (Irinotecan) | Irinotecan |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q281044 (topoisomerase inhibitor) | topoisomerase inhibitor |
| P2868 | subject has role | ... | Q2126468 (radiosensitizer) | radiosensitizer |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q50377179 (topoisomerase I inhibitor) | topoisomerase I inhibitor |
| P2868 | subject has role | ... | Q50377200 (phytogenic antineoplastic agents) | phytogenic antineoplastic agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | irinotecan | ??? |
Why not click here or view trends?
log id: 2554014